The molecular cytometer is for use in the analysis of molecular tag labeled particles.

The present invention relates to a molecular marker related to a nuclear-genetic male sterility gene and a certification method using the same.

Provided is a prognostic molecular marker for breast cancer recurrence.

The method allows one to identify a first molecular marker linked to a quantitative trait locus (QTL) and a second molecular marker linked to a modifying locus having an epistatic effect in combination with the QTL.

EphA2 serves as a useful molecular marker for cancer in such areas as diagnosis and prognosis.

A catalog (34) of molecular marker tests specifies molecular marker tests annotated with clinical applicability annotations.

The molecular marker may be in the form of a proteinaceous molecule or a genetic sequence.

The system initially receives a mapping of each characteristic of the biomolecules to the corresponding molecular weight of the molecular tag.

The present invention relates to a molecular marker for discrimination of ms3, a nuclear-genetic male sterility gene, and the certification method using the same.

These data have shown that PPP-1 form a molecularly

The A26-5 gene insertion event can serve as a molecular marker for use in increasing breeding efficiency.

A molecular marker for a gene determining fructose to glucose ratio in mature tomato fruit.

The present invention provides a molecular marker for the identification of pluripotent pre-mesenchymal, pre-hematopoietic stem cells.

Nestin has been identified as a molecular marker for pancreatic stem cells, while cytokeratin-19 serves as a marker for a distinct class of islet ductal cells.

In the seeds of the deposit the QTL is linked to a molecular marker according to SEQ ID NO 1.